Long-term efficacy and safety of flecainide for supraventricular tachycardia

The American Journal of Cardiology

Volumn 62, Issue 6, 1988, Pages 56-61

  Neuss, Helmut ^a   Schlepper, Martin ^a  

^a St Vincenz Hospital   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

FLECAINIDE;

FOLLOW UP; HALLUCINATION; HEART ELECTROPHYSIOLOGY; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SUPRAVENTRICULAR TACHYCARDIA; TASTE DISORDER; VERTIGO; VISUAL IMPAIRMENT;

CARDIAC PACING, ARTIFICIAL; CLINICAL TRIALS; ELECTROCARDIOGRAPHY; ELECTROPHYSIOLOGY; FLECAINIDE; FOLLOW-UP STUDIES; HUMAN; TACHYCARDIA, ATRIOVENTRICULAR NODAL REENTRY; TACHYCARDIA, SUPRAVENTRICULAR; TIME FACTORS; WOLFF-PARKINSON-WHITE SYNDROME;

EID: 0023778345     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/0002-9149(88)90509-7     Document Type: Article

References (1)

1. Human plasma pharmacokinetics of flecainide acetate (R 818), a new antiarrhythmic, following single oral and intravenous doses (abstr)